Yep. Main issue is synthesis, cost, delivery, elimination rates and see if there is a therapeutic interval that make these molecules a viable treatment over the citotoxic effect. Plus you ideally want a lot of testing, from vitro to vivo. There is a lot to work on, but this could be an useful way to design molecules in a way faster way, then slim down to the most promising ones to test.